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Purpose of the study
The risk of progression to AIDS in HIV vertically infected
children is high. We aim to evaluate the incidence of pro-
gression to AIDS in children on ARV treatment from the
first years of life.
Methods
In years 1987–2008, Department of Children's Infectious
Diseases takes care of 87 HIV vertically infected children.
In 27 children HIV infection was recognized in the first
year of life, in 23/27 children ≤6 months of life (group I),
and in 4/27 from 6 to 12 months (group II). All children
received ARV treatment after the diagnosis. The time of
observation was from 9 months to 14 years. Clinical and
immunological staging in time of diagnosis, illness pro-
gression (according to CDC) and current staging of HIV
infection were evaluated.
Summary of results
At time of diagnosis in group I (n = 23), there were: six
children with severe immunodeficiency, three with mild
immunodeficiency, and 14 children without immunode-
ficiency. Mild signs of infections were presented in 16
children, moderate in three and four children presented
AIDS. During observation time immunological progres-
sion occurred in four children. At present neither of them
have immunodeficiency, three children have moderate
symptoms and 20 children is without immunodeficiency.
In group II (n = 4) in time to recognition there were: two
children with severe immunodeficiency, one with mild
immunodeficiency and one child without immunodefi-
ciency. Mild signs of infection were presented in one
child, in one moderate and two children presented AIDS.
During observation immunological and clinical progres-
sion occurred in two children. At present neither of them
have immunodeficiency and present mild signs of infec-
tion.
In 14/27 children the ARV treatment was initiated without
signs of disease and in good immunological status. No
child has progression to AIDS. Currently none of them
have immunodeficiency, 25/27 have mild signs of dis-
ease. Two children presenting HIV-encephalopathy recog-
nized at the same time as HIV infection.
Conclusion
Early initiation of antiretroviral treatment inhibits pro-
gression of HIV disease.
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